Locations:
SearchAdvertisement
Guidance from international committee on differential diagnoses and diagnostic approach
New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities
It’s time to get familiar with this emerging demyelinating disorder
Heightened awareness of this rare disorder may lead to better diagnosis and treatment progress
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Insights on the decision process for selecting a treatment approach
New reports focus on neuroimaging biomarkers and features of atypical presentations
Perhaps, with caveats: sNfL elevation has low sensitivity and lags MRI activity by at least a month
Early experience with the agents confirms findings from clinical trials
Findings challenge dogma that microglia are exclusively destructive regardless of location in brain
New review distills insights from studies over the past decade
Advertisement
Advertisement